Söderhäll M, Normark S, Ishikawa K, Karlsson K, Teneberg S, Winberg J, Möllby R
Department of Nephrology, Karolinska Hospital, Karolinska Institute, S-171 76 Stockholm.
J Clin Invest. 1997 Jul 15;100(2):364-72. doi: 10.1172/JCI119542.
Clinical observations suggest that immune mechanisms affect etiology and course of recurrent cystitis. A primate infection model was used to show that primary bladder infection with a uropathogenic P-fimbriated strain (binding to globoside present in the bladder wall) protects against rechallenge with homologous as well as heterologous Escherichia coli strains for up to 5-6 mo. In contrast, mutant derivatives producing P-fimbriae either lacking the tip adhesin protein or carrying an adhesin for which no bladder receptor was present, were unable to induce protection, even though they generated bladder infections of similar duration as the wild type. Therefore, the protective effect mediated by the adhesin seemed to depend upon the presence of its cognate receptor. Since the wild strain also mediated protection against mutants that lacked the adhesin, our data suggest that the globoside-binding PapG adhesin acts as an adjuvant during infection to enhance a specific response against other bacterial antigens. In fact, the globoside-binding strain DS17, but not the mutant DS17-1, unable to bind to membrane-bound globoside, elicited a secretory IgA response to LPS in urine. These in vivo findings suggest that bacterial adhesin-ligand interactions may have signaling functions of importance for the immune response.
临床观察表明,免疫机制影响复发性膀胱炎的病因和病程。利用灵长类动物感染模型显示,原发性膀胱感染致病性P菌毛菌株(与膀胱壁中存在的糖苷脂结合)可在长达5 - 6个月的时间内抵御同源及异源大肠杆菌菌株的再次攻击。相比之下,产生P菌毛的突变衍生物,要么缺乏顶端粘附蛋白,要么携带不存在膀胱受体的粘附素,即使它们引发的膀胱感染持续时间与野生型相似,也无法诱导产生保护作用。因此,由粘附素介导的保护作用似乎取决于其同源受体的存在。由于野生菌株也介导了对缺乏粘附素的突变体的保护作用,我们的数据表明,结合糖苷脂的PapG粘附素在感染期间作为佐剂发挥作用,以增强针对其他细菌抗原的特异性反应。事实上,结合糖苷脂的菌株DS17,但不包括无法结合膜结合糖苷脂的突变体DS17 - 1,引发了对尿液中LPS的分泌型IgA反应。这些体内研究结果表明,细菌粘附素 - 配体相互作用可能对免疫反应具有重要的信号传导功能。